Q4 2017 Holdings
Filed 2018-03-02 | 65 holdings | $43.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $284 | 70,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $395 | 18,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $562 | 15,000 | 0.0% |
| Radius Health Inc | COM | 750469207 | $597 | 18,799 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $617 | 12,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $660 | 34,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $773 | 39,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $834 | 20,953 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $843 | 58,600 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $883 | 14,779 | 0.0% |
| Spring BR Pharmaceuticals Inc | COM | 849431101 | $956 | 73,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $1.0K | 69,000 | 0.0% |
| Reshape Lifesciences Inc | COM | 761123108 | $1.2K | 788,194 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $1.2K | 24,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $1.2K | 12,000 | 0.0% |
| Optinose Inc | COM | 68404V100 | $1.2K | 65,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $1.3K | 9,600 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.3K | 145,000 | 0.0% |
| Merus NV | COM | NS749R100 | $1.4K | 75,060 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $1.5K | 31,400 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.5K | 27,000 | 0.0% |
| Transenterix Inc | COM | 89366M201 | $1.7K | 889,082 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $1.7K | 17,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $1.7K | 77,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $1.9K | 17,000 | 0.0% |
| Achaogen Inc | COM | 004449104 | $2.2K | 204,538 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $2.3K | 50,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $2.3K | 25,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.3K | 382,838 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $2.5K | 247,587 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $2.5K | 115,500 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.6K | 51,500 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.9K | 37,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $3.0K | 108,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $3.0K | 185,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $3.1K | 57,500 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.1K | 322,436 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $3.4K | 1,505,804 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $3.6K | 20,000 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM | 53220K504 | $4.0K | 29,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $4.5K | 253,500 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $4.8K | 31,200 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $5.2K | 76,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $5.7K | 282,633 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.1K | 477,500 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $6.3K | 36,104 | 0.0% |
| Tesaro Inc | COM | 881569107 | $6.4K | 77,300 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.9K | 72,975 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $7.7K | 492,930 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $8.3K | 341,468 | 0.0% |